Table 3 Maximum vaccine effectiveness
| Â | Argentina | Brazil | Chile | Colombia | Mexico | Peru |
|---|---|---|---|---|---|---|
| Â | Â | PHiD-CV | ||||
All-cause pneumonia (hospitalized) | 25% | 25% | 25% | 25% | 25% | 25% |
All-cause pneumonia (ambulatory) | 4.30% | 4.30% | 4.30% | 4.30% | 4.30% | 4.30% |
All-cause AOM* | 29.90% | 18% | 24.60% | 18.20% | 20.70% | 18.20% |
Myringotomy procedure | 85.80% | 51.72% | 70.53% | 52.13% | 59.55% | 52.13% |
IPD†| 76.29% | 77.82% | 71.60% | 80.41% | 67.73% | 69.99% |